ELCC 2020: Industry Participation

The European Lung Cancer Congress 2020 (ELCC 2020), is the most important congress in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2020

  • Expecting over 2000 international participants
  • Specialists and Key Opinion Leaders (KOLs) from all over the world in one place and as one community
  • 15 educational and 4 key note lectures
  • An internationally renowned faculty
  • 9 Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ELCC Congresses over the years.


Past attendees


Abbott Laboratories Daiichi Sankyo Oncology Europe GmbH Olympus Medical Systems Europe
AbbVie Elsevier Otsuka Pharmaceuticals
Agennix Eli Lilly and Company Pfizer Oncology
Amgen Epigenomics PharmaMar, S.A.
Amoy Diagnostics Co. Ltd GE Healthcare prIME Oncology
Ariad Pharmaceuticals GSK Qiagen
AstraZeneca Helsinn Healthcare Roche
Bavarian Nordic Incyte Rosetta Genomics
Bayer Karl Storz Sanofi
Beacon Merck-Pfizer Alliance Sysmex Europe GmbH
Biocartis Merck Serono Takeda Pharmaceuticals International AG
Boehringer Ingelheim Microsulis Medical Ltd. Thermo Fisher Scientific
Bristol-Myers Squibb MSD Varian Medical Systems
Cis Bio International Neogenomics Wisepress Ltd
Clovis Oncology Novartis  

How can I participate in ELCC 2020?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congresses.Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!